Hims & Hers Health (NYSE:HIMS) will report Q2 2026 results and host a 5:00 p.m. ET earnings call Aug. 10 as it positions to capture up to 20% of a $2.2B telehealth peptide market with in‑house manufacturing, even as Chief Accounting Officer Irene Becklund plans to depart Oct. 9.
Previous Week Recap
- Hims & Hers Q2 2026 Results: Hims & Hers Health (HIMS) will report Q2 2026 results after market close on Monday, August 10, 2026, and hold a 5:00 p.m. ET earnings call and webcast (archived one year).
- Hims & Hers Taps Telehealth Peptide Market: Hims & Hers (HIMS) could capture up to 20% of a $2.2B telehealth peptide market; company has peptide manufacturing facilities and infrastructure to support peptide sales.
- CAO Irene Becklund To Depart: Hims & Hers Health (HIMS) said Chief Accounting Officer Irene Becklund will leave Oct. 9. CFO Yemi Okupe will act as interim CAO; Becklund will advise during the search for a successor.
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.